1. 1) Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am. J. Gastroenterol., 105, 822–832 (2010).
2. 2) Tamura A, Tomita T, Oshima T, Toyoshima F, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Ikehara H, Ohda Y, Fukui H, Watari J, Miwa H. Prevalence and self-recognition of chronic constipation: results of an internet survey. J. Neurogastroenterol. Motil., 22, 677–685 (2016).
3. 3) Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Aliment. Pharmacol. Ther., 31, 938–949 (2010).
4. 4) Crowell MD, Harris LA, Lunsford TN, Dibaise JK. Emerging drugs for chronic constipation. Expert Opin. Emerg. Drugs, 14, 493–504 (2009).
5. 5) Nyrop KA, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ, Whitehead WE. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment. Pharmacol. Ther., 26, 237–248 (2007).